SUCCESS STORIES

  1. GxP Inventory Delivers Real-Time Visibility, Operational Efficiency 11/17/2025

    Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

  2. Transforming Clinical Supply Planning From Spreadsheets To Smart Forecasting 11/17/2025

    Streamline your clinical supply forecasting and reduce risk by moving beyond manual spreadsheets to an integrated, real-time supply management solution.

  3. Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy 9/23/2025

    Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Explore implementation strategies, lessons learned, and measurable results.

  4. Analytics–Powered Approach To Patient Recruitment Strategy 7/15/2025

    In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.

  5. RTSM And Clinical Drug Dispensation 7/16/2024

    A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

  6. Our Unified Platform Serves As eSource For COVID Treatment Trial 6/17/2024

    Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.

  7. Consolidating Clinical Supply Chain Operations With GxP Inventory 4/18/2024

    A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

  8. RTSM: Randomization And Cohort Management, IP Inventory Management 4/17/2024

    Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

  9. Unified Platform Supports Rapid Implementation Of Rescue Study 1/17/2024

    Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.

  10. eSource For A COVID Treatment Trial 1/17/2024

    Unearth how this emerging biopharmaceutical company was able to overcome challenges to successfully facilitate a Phase 2 trial for a COVID-19 treatment in critically ill patients.